1256388-49-4 Usage
Uses
Used in Pharmaceutical Industry:
(6S)-6-[5-(7-Bromo-9,9-difluoro-9H-fluoren-2-yl)-1H-imidazol-2-yl]-5-azaspiro[2.4]heptane-5-carboxylic acid phenylmethyl ester is used as a potential pharmaceutical compound for its unique molecular structure and halogenated nature, which may contribute to its interaction with biological targets and therapeutic applications.
Used in Chemical Research:
This complex organic compound is used as a subject of study in chemical research, where its properties, reactivity, and potential applications can be explored, given its unique structural features and the presence of halogen atoms.
Used in Material Science:
(6S)-6-[5-(7-Bromo-9,9-difluoro-9H-fluoren-2-yl)-1H-imidazol-2-yl]-5-azaspiro[2.4]heptane-5-carboxylic acid phenylmethyl ester may be utilized in material science for the development of new materials with specific properties, such as improved stability or reactivity, due to its halogenated and spiro clinical features.
Check Digit Verification of cas no
The CAS Registry Mumber 1256388-49-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,5,6,3,8 and 8 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1256388-49:
(9*1)+(8*2)+(7*5)+(6*6)+(5*3)+(4*8)+(3*8)+(2*4)+(1*9)=184
184 % 10 = 4
So 1256388-49-4 is a valid CAS Registry Number.
1256388-49-4Relevant academic research and scientific papers
METHOD OF PREPARATION FOR LEDIPASVIR AND DERIVATIVE THEREOF, AND INTERMEDIATE COMPOUND FOR PREPARATION OF LEDIPASVIR
-
, (2018/04/14)
Methods of preparing Ledipasvir and derivatives thereof, and intermediate compounds used in the preparation of Ledipasvir are provided. Specifically, a method for preparing the compounds of formula 1 and a series of preparation methods of preparing Ledipasvir are provided. The methods described herein are simple and efficient, and have better application prospects.
METHODS FOR TREATING HCV
-
Page/Page column 88-89, (2013/03/28)
This invention relates to combinations of therapeutic molecules useful for treating hepatitis C virus infection. The present invention relates to methods, uses, dosing regimens, and compositions.
METHODS FOR TREATING HCV
-
Paragraph 0344, (2013/10/22)
This invention relates to combinations of therapeutic molecules useful for treating hepatitis C virus infection. The present invention relates to methods, uses, dosing regimens, and compositions.
